281 related articles for article (PubMed ID: 17293853)
1. Intrinsic ubiquitination activity of PCAF controls the stability of the oncoprotein Hdm2.
Linares LK; Kiernan R; Triboulet R; Chable-Bessia C; Latreille D; Cuvier O; Lacroix M; Le Cam L; Coux O; Benkirane M
Nat Cell Biol; 2007 Mar; 9(3):331-8. PubMed ID: 17293853
[TBL] [Abstract][Full Text] [Related]
2. hnRNP K: an HDM2 target and transcriptional coactivator of p53 in response to DNA damage.
Moumen A; Masterson P; O'Connor MJ; Jackson SP
Cell; 2005 Dec; 123(6):1065-78. PubMed ID: 16360036
[TBL] [Abstract][Full Text] [Related]
3. E4F1 is an atypical ubiquitin ligase that modulates p53 effector functions independently of degradation.
Le Cam L; Linares LK; Paul C; Julien E; Lacroix M; Hatchi E; Triboulet R; Bossis G; Shmueli A; Rodriguez MS; Coux O; Sardet C
Cell; 2006 Nov; 127(4):775-88. PubMed ID: 17110336
[TBL] [Abstract][Full Text] [Related]
4. The histone acetyltransferase PCAF regulates p21 transcription through stress-induced acetylation of histone H3.
Love IM; Sekaric P; Shi D; Grossman SR; Androphy EJ
Cell Cycle; 2012 Jul; 11(13):2458-66. PubMed ID: 22713239
[TBL] [Abstract][Full Text] [Related]
5. p73gamma transactivates the p21 promoter through preferential interaction with the p300/CBP-associated factor in human prostate cancer cells.
Momii Y; Izumi H; Shiota M; Onitsuka T; Abe T; Kobayashi H; Miyamoto N; Uchiumi T; Kohno K
Oncol Rep; 2007 Aug; 18(2):411-6. PubMed ID: 17611664
[TBL] [Abstract][Full Text] [Related]
6. Small molecule inhibitors of HDM2 ubiquitin ligase activity stabilize and activate p53 in cells.
Yang Y; Ludwig RL; Jensen JP; Pierre SA; Medaglia MV; Davydov IV; Safiran YJ; Oberoi P; Kenten JH; Phillips AC; Weissman AM; Vousden KH
Cancer Cell; 2005 Jun; 7(6):547-59. PubMed ID: 15950904
[TBL] [Abstract][Full Text] [Related]
7. Alterations in gene expression and sensitivity to genotoxic stress following HdmX or Hdm2 knockdown in human tumor cells harboring wild-type p53.
Heminger K; Markey M; Mpagi M; Berberich SJ
Aging (Albany NY); 2009 Jan; 1(1):89-108. PubMed ID: 19946469
[TBL] [Abstract][Full Text] [Related]
8. The acetyltransferase p300/CBP-associated factor is a p53 target gene in breast tumor cells.
Watts GS; Oshiro MM; Junk DJ; Wozniak RJ; Watterson S; Domann FE; Futscher BW
Neoplasia; 2004; 6(3):187-94. PubMed ID: 15153330
[TBL] [Abstract][Full Text] [Related]
9. HIPK2 contributes to PCAF-mediated p53 acetylation and selective transactivation of p21Waf1 after nonapoptotic DNA damage.
Di Stefano V; Soddu S; Sacchi A; D'Orazi G
Oncogene; 2005 Aug; 24(35):5431-42. PubMed ID: 15897882
[TBL] [Abstract][Full Text] [Related]
10. MDM2 inhibits PCAF (p300/CREB-binding protein-associated factor)-mediated p53 acetylation.
Jin Y; Zeng SX; Dai MS; Yang XJ; Lu H
J Biol Chem; 2002 Aug; 277(34):30838-43. PubMed ID: 12068014
[TBL] [Abstract][Full Text] [Related]
11. A new function for p53 ubiquitination.
Hirano Y; Ronai Z
Cell; 2006 Nov; 127(4):675-7. PubMed ID: 17110328
[TBL] [Abstract][Full Text] [Related]
12. Mdm2 and PCAF increase Chk2 ubiquitination and degradation independently of their intrinsic E3 ligase activities.
Kass EM; Poyurovsky MV; Zhu Y; Prives C
Cell Cycle; 2009 Feb; 8(3):430-7. PubMed ID: 19176998
[TBL] [Abstract][Full Text] [Related]
13. SIAH-mediated ubiquitination and degradation of acetyl-transferases regulate the p53 response and protein acetylation.
Grishina I; Debus K; García-Limones C; Schneider C; Shresta A; García C; Calzado MA; Schmitz ML
Biochim Biophys Acta; 2012 Dec; 1823(12):2287-96. PubMed ID: 23044042
[TBL] [Abstract][Full Text] [Related]
14. TRIAD1 inhibits MDM2-mediated p53 ubiquitination and degradation.
Bae S; Jung JH; Kim K; An IS; Kim SY; Lee JH; Park IC; Jin YW; Lee SJ; An S
FEBS Lett; 2012 Sep; 586(19):3057-63. PubMed ID: 22819825
[TBL] [Abstract][Full Text] [Related]
15. HdmX stimulates Hdm2-mediated ubiquitination and degradation of p53.
Linares LK; Hengstermann A; Ciechanover A; Müller S; Scheffner M
Proc Natl Acad Sci U S A; 2003 Oct; 100(21):12009-14. PubMed ID: 14507994
[TBL] [Abstract][Full Text] [Related]
16. Tip60-dependent acetylation of p53 modulates the decision between cell-cycle arrest and apoptosis.
Tang Y; Luo J; Zhang W; Gu W
Mol Cell; 2006 Dec; 24(6):827-39. PubMed ID: 17189186
[TBL] [Abstract][Full Text] [Related]
17. To die or not to die: a HAT trick.
Tyteca S; Legube G; Trouche D
Mol Cell; 2006 Dec; 24(6):807-8. PubMed ID: 17189182
[TBL] [Abstract][Full Text] [Related]
18. A regulatory loop composed of RAP80-HDM2-p53 provides RAP80-enhanced p53 degradation by HDM2 in response to DNA damage.
Yan J; Menendez D; Yang XP; Resnick MA; Jetten AM
J Biol Chem; 2009 Jul; 284(29):19280-9. PubMed ID: 19433585
[TBL] [Abstract][Full Text] [Related]
19. PCAF ubiquitin ligase activity inhibits Hedgehog/Gli1 signaling in p53-dependent response to genotoxic stress.
Mazzà D; Infante P; Colicchia V; Greco A; Alfonsi R; Siler M; Antonucci L; Po A; De Smaele E; Ferretti E; Capalbo C; Bellavia D; Canettieri G; Giannini G; Screpanti I; Gulino A; Di Marcotullio L
Cell Death Differ; 2013 Dec; 20(12):1688-97. PubMed ID: 24013724
[TBL] [Abstract][Full Text] [Related]
20. The kinetics of p53-binding and histone acetylation at target promoters do not strictly correlate with gene expression after UV damage.
Magrini R; Russo D; Fronza G; Inga A; Menichini P
J Cell Biochem; 2007 Apr; 100(5):1276-87. PubMed ID: 17063487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]